首页> 外国专利> CERTAIN IMPROVED HUMAN BISPECIFIC EGFRVIII ANTIBODY ENGAGING MOLECULES

CERTAIN IMPROVED HUMAN BISPECIFIC EGFRVIII ANTIBODY ENGAGING MOLECULES

机译:某些改善了人类双特异性EGFRVIII抗体参与分子

摘要

We have constructed a polynucleotide encoding a bispecific antibody engaging molecule which has one arm that specifically engages a tumor cell which expresses the human EGFRvIII mutant protein on its surface, and a second arm that specifically engages T cell activation ligand CD3. The polynucleotide is codon optimized for expression in CHO cells. The subunits of the engaging molecules are organized to achieve greater efficiency. These are promising therapeutic agents.
机译:我们已经构建了编码双特异性抗体结合分子的多核苷酸,该分子具有一个臂,该臂特异性地接合在其表面表达人EGFRvIII突变蛋白的肿瘤细胞,而第二个臂特异性地接合T细胞活化配体CD3。对多核苷酸进行密码子优化以在CHO细胞中表达。结合分子的亚基被组织以获得更高的效率。这些是有前途的治疗剂。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号